Results
|
|
581.
|
|
|
|
582.
|
Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies: M. Gelbard, I. Goldstein, W. J. Hellstrom, C. G. McMahon, T. Smith, J. Tursi, N. Jones, G. J. Kaufman and C. C. Carson, III J Urol 2013; 190: 199-207. [electronic resource] by Producer: 20140414
In:
The Journal of urology vol. 191
Availability: No items available.
|
|
|
583.
|
|
|
|
584.
|
|
|
|
585.
|
|
|
|
586.
|
|
|
|
587.
|
|
|
|
588.
|
|
|
|
589.
|
|
|
|
590.
|
|
|
|
591.
|
|
|
|
592.
|
|
|
|
593.
|
|
|
|
594.
|
|
|
|
595.
|
|
|
|
596.
|
|
|
|
597.
|
|
|
|
598.
|
|
|
|
599.
|
|
|
|
600.
|
|